Skip to Main Content

Author Details

Dhaval Patel
National Cancer Institute, National Institutes of Health
1991
107
30
PMIDPaper TitleJournal TitlePublished Year
34735022Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.Cancer2022
36111275Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.J Endocr Soc2022
34735022Management recommendations for pancreatic manifestations of von Hippel-Lindau disease.Cancer2022
36111275Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.J Endocr Soc2022
33069680Congenitally Abnormal Aortic Valve Causing Coronary Obstruction and Cardiac Arrest in Infancy.Ann Thorac Surg2021
33069680Congenitally Abnormal Aortic Valve Causing Coronary Obstruction and Cardiac Arrest in Infancy.Ann Thorac Surg2021
34705847Profile of Medicaid enrollees with sickle cell disease: A high need, high cost population.PLoS One2021
34705847Profile of Medicaid enrollees with sickle cell disease: A high need, high cost population.PLoS One2021
31522749Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.Surgery2020
3213020018F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.Endocrinol Diabetes Metab Case Rep2020
32112213Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.Ann Surg Oncol2020
32112212Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.Ann Surg Oncol2020
32206597Surgical approach to patients with pheochromocytoma.Gland Surg2020
32934779GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.Oncotarget2020
32706863Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.J Clin Endocrinol Metab2020
32698142Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.Endocr Relat Cancer2020
32572525Perioperative Management and Outcomes of Hyperthyroid Patients Unable to Tolerate Antithyroid Drugs.World J Surg2020
31522749Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.Surgery2020
31531722Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels.World J Surg2020
32572525Perioperative Management and Outcomes of Hyperthyroid Patients Unable to Tolerate Antithyroid Drugs.World J Surg2020
32934779GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3.Oncotarget2020
32706863Distinct DNA Methylation Signatures in Neuroendocrine Tumors Specific for Primary Site and Inherited Predisposition.J Clin Endocrinol Metab2020
32698142Epidural anesthesia and hypotension in pheochromocytoma and paraganglioma.Endocr Relat Cancer2020
32112213Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma.Ann Surg Oncol2020
32112212Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine/Head and Neck Disease-Site Work Group. Part 1 of 2: Advances in Pathogenesis and Diagnosis of Pheochromocytoma and Paraganglioma.Ann Surg Oncol2020
32206597Surgical approach to patients with pheochromocytoma.Gland Surg2020
3213020018F-FDOPA PET/CT accurately identifies MEN1-associated pheochromocytoma.Endocrinol Diabetes Metab Case Rep2020
31531722Surgical Resection of Pheochromocytomas and Paragangliomas is Associated with Lower Cholesterol Levels.World J Surg2020
29334561Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.Ann Surg2019
31733070Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma.J Surg Oncol2019
31620364Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).Front Oncol2019
30267071Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.JAMA Surg2019
30398411Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.Thyroid2019
30327187Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.Surgery2019
30414705High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.Surgery2019
30620390Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.Cancer2019
29334561Preoperative 18F-FDG PET/CT in Pheochromocytomas and Paragangliomas Allows for Precision Surgery.Ann Surg2019
30865533ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.Endocr Pract2019
30777201The utility of <sup>68</sup>Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.Eur J Radiol2019
31146085MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.J Surg Res2019
31733070Preoperative systemic inflammatory markers are prognostic indicators in recurrent adrenocortical carcinoma.J Surg Oncol2019
31620364Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).Front Oncol2019
30777201The utility of <sup>68</sup>Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.Eur J Radiol2019
30865533ONCOGENE PANEL SEQUENCING ANALYSIS IDENTIFIES CANDIDATE ACTIONABLE GENES IN ADVANCED WELL-DIFFERENTIATED GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS.Endocr Pract2019
31146085MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.J Surg Res2019
30398411Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness.Thyroid2019
30267071Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.JAMA Surg2019
30620390Distinct genome-wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors.Cancer2019
30414705High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy.Surgery2019
30327187Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.Surgery2019
  • 1 - 50 of 214

Recommended Authors

Kee Yuan Ngiam
Yong Loo Lin School of Medicine, National University of Singapore
Career Start Year 2013
Number of shared co-authors 0
Tristan Grogan
University of California Los Angeles
Career Start Year 2013
Number of shared co-authors 0
Colin O'Rourke
Center for Interventional Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 2011
Number of shared co-authors 0
Niamh Conlon
Cork University Hospital
Career Start Year 2006
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Jocelyn F Burke
Kirk Kerkorian School of Medicine of University of Nevada
Career Start Year 2002
Number of shared co-authors 0
Yen-Lin Chen
34903Fu-Jen Catholic University
Career Start Year 2001
Number of shared co-authors 0
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Ji Young Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 1
Ji Eun Lee
Soonchunhyang University College of Medicine, Bucheon Hospital
Career Start Year 1999
Number of shared co-authors 0
Chuong Bui
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Sun Young Lee
Chonbuk National University Hospital
Career Start Year 1998
Number of shared co-authors 0
Woo Young Kim
Westchester Medical Center
Career Start Year 1998
Number of shared co-authors 0
Tobias Else
Harvard Medical School
Career Start Year 1997
Number of shared co-authors 3
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Elizabeth Wu
Brown University Warren Alpert Medical School
Career Start Year 1996
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Hyo Jin Kim
Department of Food Bioengineering, Jeju National University
Career Start Year 1996
Number of shared co-authors 0
Eun Young Kim
College of Korean Medicine, Kyung Hee University
Career Start Year 1995
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 8
Hyun-Soo Kim
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 0
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Career Start Year 1992
Number of shared co-authors 7
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year 1991
Number of shared co-authors 0
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 6
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 1
Daniel Picard
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year 1981
Number of shared co-authors 0
Clive S Grant
Inova Health System
Career Start Year 1979
Number of shared co-authors 2
Judith D Goldberg
NYU Grossman School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Electron Kebebew
Stanford University School of Medicine
Co-authored papers 65
Naris Nilubol
Center for Cancer Research
Co-authored papers 56
Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 19
Karel Pacak
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers 14
Myriem Boufraqech
The University of Texas at Austin
Co-authored papers 14
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers 12
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Co-authored papers 11
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 11
Ryan J Ellis
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Sunita K Agarwal
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 7
Stephen J Marx
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 6
William F Simonds
Co-authored papers 6
Yi Liu-Chittenden
Department of Biochemistry and Howard Hughes Medical Institute, Stanford University
Co-authored papers 5
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 5
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 5
Mei He
Sichuan University
Co-authored papers 4
Meenu Jain
Georgia Cancer Center, Augusta University
Co-authored papers 4
Amit Mehta
Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
Co-authored papers 4
William Marston Linehan
Co-authored papers 3
Kelli Gaskins
Frederick National Laboratory for Cancer Research, National Institutes of Health
Co-authored papers 3
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 3
Jonathan K Killian
From Foundation Medicine
Co-authored papers 3
Rachel Aufforth
The University of North Carolina
Co-authored papers 3
Yaqin Zhang
Jiangsu University Zhenjiang 212013
Co-authored papers 3
Holly Stevenson
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Susan R Davis
Co-authored papers 2
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Markku Miettinen
National Cancer Institute
Co-authored papers 2
Yonghong Wang
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Release 1.2